Published in Virus Res on February 01, 2005
Quasispecies theory and the behavior of RNA viruses. PLoS Pathog (2010) 3.19
Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell (2012) 2.94
Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J Biol Chem (2005) 2.40
Genome-wide diversity and selective pressure in the human rhinovirus. Virol J (2007) 1.94
De novo assembly of highly diverse viral populations. BMC Genomics (2012) 1.87
Plaques Formed by Mutagenized Viral Populations Have Elevated Coinfection Frequencies. MBio (2017) 1.73
Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog (2010) 1.67
Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. Proc Natl Acad Sci U S A (2012) 1.65
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat Rev Drug Discov (2013) 1.64
Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J Virol (2006) 1.56
Quasispecies made simple. PLoS Comput Biol (2005) 1.56
High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J Virol (2007) 1.54
T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro. J Virol (2013) 1.34
Coxsackievirus B3 mutator strains are attenuated in vivo. Proc Natl Acad Sci U S A (2012) 1.32
Rationalizing the development of live attenuated virus vaccines. Nat Biotechnol (2010) 1.26
Structure-function relationships of the viral RNA-dependent RNA polymerase: fidelity, replication speed, and initiation mechanism determined by a residue in the ribose-binding pocket. J Biol Chem (2007) 1.23
Molecular dynamics simulations of viral RNA polymerases link conserved and correlated motions of functional elements to fidelity. J Mol Biol (2011) 1.22
Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus. J Virol (2007) 1.15
Broad action of Hsp90 as a host chaperone required for viral replication. Biochim Biophys Acta (2011) 1.13
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase. PLoS One (2013) 1.12
A multi-step process of viral adaptation to a mutagenic nucleoside analogue by modulation of transition types leads to extinction-escape. PLoS Pathog (2010) 1.08
Mutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461. PLoS One (2011) 1.08
Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance. J Virol (2009) 1.07
Potential use of antiviral agents in polio eradication. Emerg Infect Dis (2008) 1.05
Lethal mutagenesis of bacteria. Genetics (2008) 1.05
A cross-species view on viruses. Curr Opin Virol (2012) 1.01
Alphavirus mutator variants present host-specific defects and attenuation in mammalian and insect models. PLoS Pathog (2014) 1.00
Examining the theory of error catastrophe. J Virol (2006) 1.00
Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence. J Virol (2005) 0.98
Genus-specific substitution rate variability among picornaviruses. J Virol (2011) 0.96
Hepatitis C virus genetic variability and evolution. World J Hepatol (2015) 0.96
Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin. PLoS One (2010) 0.95
Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother (2012) 0.95
Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerases. J Med Chem (2006) 0.93
Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture. J Virol (2012) 0.90
Synthesis of a universal 5-nitroindole ribonucleotide and incorporation into RNA by a viral RNA-dependent RNA polymerase. Chembiochem (2007) 0.87
Selection of hepatitis C virus resistant to ribavirin. Virol J (2011) 0.86
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. Antiviral Res (2011) 0.85
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut (2016) 0.84
Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection. J Virol (2011) 0.83
Sequence-Specific Fidelity Alterations Associated with West Nile Virus Attenuation in Mosquitoes. PLoS Pathog (2015) 0.83
Structural dynamics as a contributor to error-prone replication by an RNA-dependent RNA polymerase. J Biol Chem (2014) 0.82
Structural features of a picornavirus polymerase involved in the polyadenylation of viral RNA. J Virol (2013) 0.82
RNA Viruses and RNAi: Quasispecies Implications for Viral Escape. Viruses (2015) 0.78
The murine model for Hantaan virus-induced lethal disease shows two distinct paths in viral evolutionary trajectory with and without ribavirin treatment. J Virol (2013) 0.78
Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population. PLoS One (2012) 0.77
Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach. J Virol (2016) 0.76
Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations. Viruses (2016) 0.76
Poliovirus evolution: the strong, silent type. Cell Host Microbe (2012) 0.76
Cell-specific establishment of poliovirus resistance to an inhibitor targeting a cellular protein. J Virol (2015) 0.76
Generation of a genetically stable high-fidelity influenza vaccine strain. J Virol (2017) 0.75
Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens. J Virol (2016) 0.75
[KIL-d] Protein Element Confers Antiviral Activity via Catastrophic Viral Mutagenesis. Mol Cell (2015) 0.75
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature (2005) 6.78
Short interfering RNA confers intracellular antiviral immunity in human cells. Nature (2002) 5.27
The RNA silencing endonuclease Argonaute 2 mediates specific antiviral immunity in Drosophila melanogaster. Genes Dev (2006) 4.26
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell (2010) 4.07
Quasispecies theory and the behavior of RNA viruses. PLoS Pathog (2010) 3.19
Engineering attenuated virus vaccines by controlling replication fidelity. Nat Med (2008) 3.01
The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing. Nat Cell Biol (2006) 2.83
High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing. Proc Natl Acad Sci U S A (2013) 2.44
Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J Biol Chem (2005) 2.40
Temporal analysis of the honey bee microbiome reveals four novel viruses and seasonal prevalence of known viruses, Nosema, and Crithidia. PLoS One (2011) 2.23
Antiviral immunity in Drosophila requires systemic RNA interference spread. Nature (2009) 2.15
Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J Virol (2005) 1.98
Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe (2008) 1.94
Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev (2007) 1.87
Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing. J Virol (2003) 1.81
Ribavirin's antiviral mechanism of action: lethal mutagenesis? J Mol Med (Berl) (2001) 1.59
Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA. J Virol (2008) 1.58
Cricket paralysis virus antagonizes Argonaute 2 to modulate antiviral defense in Drosophila. Nat Struct Mol Biol (2010) 1.54
The role of mutational robustness in RNA virus evolution. Nat Rev Microbiol (2013) 1.54
Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection. J Gen Virol (2002) 1.46
Structural and functional characterization of the coxsackievirus B3 CRE(2C): role of CRE(2C) in negative- and positive-strand RNA synthesis. J Gen Virol (2006) 1.39
Codon usage determines the mutational robustness, evolutionary capacity, and virulence of an RNA virus. Cell Host Microbe (2012) 1.32
Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin. Microbes Infect (2002) 1.29
The silent treatment: RNAi as a defense against virus infection in mammals. Trends Biotechnol (2006) 1.27
Rationalizing the development of live attenuated virus vaccines. Nat Biotechnol (2010) 1.26
An RNA element at the 5'-end of the poliovirus genome functions as a general promoter for RNA synthesis. PLoS Pathog (2010) 1.14
The poliovirus 2C cis-acting replication element-mediated uridylylation of VPg is not required for synthesis of negative-sense genomes. J Gen Virol (2003) 1.13
Solution structure of a consensus stem-loop D RNA domain that plays important roles in regulating translation and replication in enteroviruses and rhinoviruses. Biochemistry (2004) 1.08
Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element. Nucleic Acids Res (2006) 1.05
The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein. J Virol (2004) 1.04
Single-cell analysis uncovers extensive biological noise in poliovirus replication. J Virol (2014) 1.02
Non-specific dsRNA-mediated antiviral response in the honey bee. PLoS One (2013) 1.00
Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex. J Cell Sci (2007) 1.00
The EDLL motif: a potent plant transcriptional activation domain from AP2/ERF transcription factors. Plant J (2012) 0.99
Identification and manipulation of the molecular determinants influencing poliovirus recombination. PLoS Pathog (2013) 0.98
Exploring the fitness landscape of an RNA virus by using a universal barcode microarray. J Virol (2011) 0.97
The systematic position of Phaeocryptopus gaeumannii. Mycologia (2007) 0.97
Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus. PLoS One (2013) 0.93
Extending the family of UNCG-like tetraloop motifs: NMR structure of a CACG tetraloop from coxsackievirus B3. Biochemistry (2003) 0.92
RNA interference-mediated intrinsic antiviral immunity in invertebrates. Curr Top Microbiol Immunol (2013) 0.92
Equine cutaneous fungal granuloma: a study of 44 lesions from 34 horses. Vet Dermatol (2006) 0.92
NMR structures of loop B RNAs from the stem-loop IV domain of the enterovirus internal ribosome entry site: a single C to U substitution drastically changes the shape and flexibility of RNA. Biochemistry (2004) 0.92
A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus. Antimicrob Agents Chemother (2008) 0.91
Manganese-dependent polioviruses caused by mutations within the viral polymerase. J Virol (2003) 0.90
Specific recognition of the C-rich strand of human telomeric DNA and the RNA template of human telomerase by the first KH domain of human poly(C)-binding protein-2. J Biol Chem (2004) 0.89
Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine. Adv Drug Deliv Rev (2004) 0.89
Characterisation and phylogenetic relationships of Anisogramma virgultorum and A. anomala in the Diaporthales (Ascomycota). Mycol Res (2008) 0.89
RNA silencing in viral infections: insights from poliovirus. Virus Res (2004) 0.85
StralSV: assessment of sequence variability within similar 3D structures and application to polio RNA-dependent RNA polymerase. BMC Bioinformatics (2011) 0.83
Global RNA structure analysis of poliovirus identifies a conserved RNA structure involved in viral replication and infectivity. J Virol (2013) 0.81
Closing the gap: the challenges in converging theoretical, computational, experimental and real-life studies in virus evolution. Curr Opin Virol (2012) 0.81
An enhanced single base extension technique for the analysis of complex viral populations. PLoS One (2009) 0.80
RNAi puts a lid on virus replication. Nat Biotechnol (2003) 0.79
Studies towards the potential of poliovirus as a vector for the expression of HPV 16 virus-like-particles. FEMS Immunol Med Microbiol (2002) 0.79
Slicer activity in Drosophila melanogaster S2 extract. Methods Mol Biol (2011) 0.78
Exploring RNA virus replication in Xenopus oocytes. Methods Mol Biol (2006) 0.78
Poliovirus: generation, quantification, propagation, purification, and storage. Curr Protoc Microbiol (2013) 0.77
Poliovirus: generation and characterization of mutants. Curr Protoc Microbiol (2013) 0.76
Comparison of taxonomic, colony morphotype and PCR-RFLP methods to characterize microfungal diversity. Mycologia (2006) 0.76
Phylogenetics of Lophodermium from pine. Mycologia (2010) 0.75
RNA Recombination Enhances Adaptability and Is Required for Virus Spread and Virulence. Cell Host Microbe (2017) 0.75
RNA structure analysis of viruses using SHAPE. Curr Protoc Microbiol (2013) 0.75
A climate-based model for predicting geographic variation in swiss needle cast severity in the Oregon coast range. Phytopathology (2005) 0.75
Demonstration manuscript illustrates the formatting required for submission to Mycologia. Mycologia (2017) 0.75
Population structure suggests reproductively isolated lineages of Phaeocryptopus gaeumannii. Mycologia (2007) 0.75